<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">346300</id>
  <title nil="true"/>
  <common-name>2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-(3-fluorophenyl)methylideneamino]acetamide</common-name>
  <description>2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-(3-fluorophenyl)methylideneamino]acetamide is a chemical compound with the formula C27H26FN5OS. It has an average molecular weight of 487.60 g/mol.</description>
  <cas>303105-60-4</cas>
  <pubchem-id>9660629</pubchem-id>
  <chemical-formula>C27H26FN5OS</chemical-formula>
  <weight>487.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T09:42:18Z</created-at>
  <updated-at type="dateTime">2026-08-31T09:42:18Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(C)(C)C1=CC=C(C=C1)C2=NN=C(N2C3=CC=CC=C3)SCC(=O)NN=CC4=CC(=CC=C4)F</moldb-smiles>
  <moldb-formula>C27H26FN5OS</moldb-formula>
  <moldb-inchi>InChI=1S/C27H26FN5OS/c1-27(2,3)21-14-12-20(13-15-21)25-31-32-26(33(25)23-10-5-4-6-11-23)35-18-24(34)30-29-17-19-8-7-9-22(28)16-19/h4-17H,18H2,1-3H3,(H,30,34)/b29-17+</moldb-inchi>
  <moldb-inchikey>JDTIDMRDCGKFOD-STBIYBPSSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">487.1842098</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM342193</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-(3-fluorophenyl)methylideneamino]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Triazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296653</sync-id>
  <structure-inchikey>JDTIDMRDCGKFOD-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>404000200000800000002800000000000000000000000000020000000000000000000402000004008000002084800000000000000000000000200000000000000000000000000000000000000020000000000210000004000010000000000000010000000000000080100000800000080104000000000000000000000001004040000000800000000000000090880000010100000000000000000000000000000000001000400000080000000040000000400000000100002c00000000000800004000000000000000000000420000000000002000000200000000000000000040000000001048000000000400800000010000000040000000004000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJgAAAIABBgBgAAAAAQMGACAAAAAE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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:45:04Z</structure-indexed-at>
</compound>
